NCT05172245 2026-03-18Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerNational Cancer Institute (NCI)Phase 1 Recruiting46 enrolled
NCT05136196 2026-03-17BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNational Cancer Institute (NCI)Phase 2 Recruiting150 enrolled